Analyst Activity – Morgan Stanley Initiates Coverage On Nabriva Therapeutics (NASDAQ:NBRV) With a Overweight

ME Staff
-
0

Analyst Ratings For Nabriva Therapeutics (NASDAQ:NBRV)

Today, Morgan Stanley initiated coverage on Nabriva Therapeutics (NASDAQ:NBRV) with a Overweight with a price target of $10.00.

Some recent analyst ratings include

  • 1/17/2018-Morgan Stanley initiated coverage with a Overweight rating.
  • 11/16/2017-HC Wainwright Reiterated Rating of Buy.
  • 9/19/2017-Needham & Company LLC Reiterated Rating of Buy.
  • 9/18/2017-Wedbush Reiterated Rating of Outperform.
  • 9/18/2017-Leerink Swann Reiterated Rating of Outperform.
  • 9/18/2017-Cantor Fitzgerald Reiterated Rating of Buy.

Recent Insider Trading Activity For Nabriva Therapeutics (NASDAQ:NBRV)
Nabriva Therapeutics (NASDAQ:NBRV) has insider ownership of 2.75% and institutional ownership of 57.12%.

  • On 11/29/2017 Francesco Maria Lavino, Insider, bought 1,569 with an average share price of $6.29 per share and the total transaction amounting to $9,869.01.
  • On 9/22/2017 Colin Md Broom, CEO, bought 2,588 with an average share price of $8.35 per share and the total transaction amounting to $21,609.80.
  • On 9/22/2017 Gary Sender, CFO, bought 2,000 with an average share price of $8.21 per share and the total transaction amounting to $16,420.00.
  • On 9/18/2017 Vivo Capital Viii, Llc, Major Shareholder, bought 52,631 with an average share price of $9.46 per share and the total transaction amounting to $497,889.26.
  • On 9/14/2017 Hbm Healthcare Investments (Ca, Major Shareholder, sold 36,608 with an average share price of $8.56 per share and the total transaction amounting to $313,364.48.
  • On 8/31/2017 Hbm Healthcare Investments (Ca, Major Shareholder, sold 639 with an average share price of $9.50 per share and the total transaction amounting to $6,070.50.
  • On 8/8/2017 Hbm Healthcare Investments (Ca, Major Shareholder, sold 19,803 with an average share price of $10.50 per share and the total transaction amounting to $207,931.50.

Recent Trading Activity for Nabriva Therapeutics (NASDAQ:NBRV)
Shares of Nabriva Therapeutics closed the previous trading session at 6.25 up +0.25 4.17% with 6.25 shares trading hands.